Aurinia Pharmaceuticals Inc (AUPH)

[rosemountbomber]

Yes, this was all priced in. No reason yet for the market to get excited. Sales are extremely slow here in the States and we (as does the market) know that Europe is a lot tougher than the U.S.

The reimbursement negotiations not only will depressing from the perspective that the EU countries will want to pay very little, but it will take a lot of time. So becoming profitable is not in the cards in the very near future.

What hopefully this means though, is that some prospective buyer gets or remains interested, seeing acceptance of the drug worldwide and we can get made whole here.